Jun Ma

h-index18
2papers
1,222citations

2 Papers

3.7CVMar 4, 2021
The MICCAI Hackathon on reproducibility, diversity, and selection of papers at the MICCAI conference

Fabian Balsiger, Alain Jungo, Naren Akash R J et al.

The MICCAI conference has encountered tremendous growth over the last years in terms of the size of the community, as well as the number of contributions and their technical success. With this growth, however, come new challenges for the community. Methods are more difficult to reproduce and the ever-increasing number of paper submissions to the MICCAI conference poses new questions regarding the selection process and the diversity of topics. To exchange, discuss, and find novel and creative solutions to these challenges, a new format of a hackathon was initiated as a satellite event at the MICCAI 2020 conference: The MICCAI Hackathon. The first edition of the MICCAI Hackathon covered the topics reproducibility, diversity, and selection of MICCAI papers. In the manner of a small think-tank, participants collaborated to find solutions to these challenges. In this report, we summarize the insights from the MICCAI Hackathon into immediate and long-term measures to address these challenges. The proposed measures can be seen as starting points and guidelines for discussions and actions to possibly improve the MICCAI conference with regards to reproducibility, diversity, and selection of papers.

9.4LGMar 16, 2018
Chemi-net: a graph convolutional network for accurate drug property prediction

Ke Liu, Xiangyan Sun, Lei Jia et al.

Absorption, distribution, metabolism, and excretion (ADME) studies are critical for drug discovery. Conventionally, these tasks, together with other chemical property predictions, rely on domain-specific feature descriptors, or fingerprints. Following the recent success of neural networks, we developed Chemi-Net, a completely data-driven, domain knowledge-free, deep learning method for ADME property prediction. To compare the relative performance of Chemi-Net with Cubist, one of the popular machine learning programs used by Amgen, a large-scale ADME property prediction study was performed on-site at Amgen. The results showed that our deep neural network method improved current methods by a large margin. We foresee that the significantly increased accuracy of ADME prediction seen with Chemi-Net over Cubist will greatly accelerate drug discovery.